May 11, 2021 / 06:45PM GMT
Tazeen Ahmad - BofA Securities, Research Division - VP
Good afternoon, everyone. Thanks for joining us at our Bank of America Healthcare Conference, usually held in Vegas. Of course, this year is virtual. We hope to go back to Vegas sometime soon. It's our pleasure to be hosting our next presenting company, Alnylam. Presenting for Alnylam is none other than John Maraganore.
John, you don't need an introduction. So I think we should probably just go straight into Q&A.
John M. Maraganore - Alnylam Pharmaceuticals, Inc. - CEO & Executive Director
Sure.
Questions and Answers:
Tazeen Ahmad - BofA Securities, Research Division - VPFor those who might not be as familiar with Alnylam, maybe we can do with super quick overview in 2 minutes, which I know is a challenge because you've got a lot going on. But hopefully, we'll be able to get into a little bit more detail on some of the key items over the course of the next 30 minutes, if that's okay.
John M. Maraganore -